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Edited by Christian GriesingerAbstract HAMLET (human alpha-lactalbumin made lethal to
tumor cells) is a complex between a-lactalbumin and oleic acid
that induces apoptosis in tumor cells, but not in healthy cells.
Heteronuclear nuclear magnetic resonance (NMR) spectroscopy
was used to determine the structure of 13C-oleic acid in HAM-
LET, and to study the 15N-labeled protein. Nuclear Overhauser
enhancement spectroscopy shows that the two ends of the fatty
acid are in close proximity and close to the double bond, indicat-
ing that the oleic acid is bound to HAMLET in a compact
conformation. The data further show that HAMLET is a partly
unfolded/molten globule-like complex under physiological condi-
tions.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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a-lactalbumin1. Introduction
HAMLET (human alpha-lactalbumin made lethal to tumor
cells) is a complex of human a-lactalbumin and oleic acid
(Fig. 1(a)), which induces apoptosis in tumor cells, but spares
healthy cells [1]. The anti-tumor activity includes over 40 diﬀer-
ent lymphoma and carcinoma cell lines [2]. HAMLET removes
skin papilloma in patients [3] and limits the progression of
human glioblastoma in a rat xenograft model [4]. HAMLET
binds to the surface of tumor cells, enters the cells, interacts
with mitochondria [5], targets ribosomes and activates casp-
ases [6]. Eventually, the protein accumulates in the cell nucleus
where it interacts with histones and disrupts chromatin struc-
ture [7].
HAMLET is produced from a-lactalbumin through removal
of bound Ca2+ and exposure to oleic acid on an ion exchangeAbbreviations: CD, circular dichroism; EDTA, ethylenediamintetra-
acetic acid; HAMLET, human alpha-lactalbumin made lethal to tumor
cells; HSQC, heteronuclear single quantum correlation; MD, molec-
ular dynamics; NMR, nuclear magnetic resonance; NOESY, nuclear
Overhauser enhancement spectroscopy
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doi:10.1016/j.febslet.2005.08.089column [8,9]. HAMLET is eluted as a complex of fatty and
protein, and has the characteristics of a protein that is kine-
tically trapped in a partly folded state [10]. It has not been
possible to produce the active complex by mixing the pure
components in solution [1].
Here, we use heteronuclear nuclear magnetic resonance
(NMR) spectroscopy to characterize the structure of the pro-
tein and the fatty acid in HAMLET. The results show that
oleic acid is bound to HAMLET in a compact fashion and that
HAMLET is a partly unfolded molten globule-like complex at
physiological conditions.2. Materials and methods
2.1. Expression and puriﬁcation of a-lactalbumin
Native a-lactalbumin was puriﬁed from human milk as described [1].
15N-labeled recombinant human a-lactalbumin was expressed from the
pAla plasmid (kindly provided by Peter S Kim [29]) in Escherichia coli
BL21 DE3 cells in M9 minimal medium containing 98% enriched
15NH4Cl2 using standard procedures. The cell pellet was sonicated in
20 mM Tris/HCl, pH 7.5, and inclusion bodies were collected by cen-
trifugation, resonicated, and dissolved by shaking overnight in 20 mM
Tris/HCl, pH 8.0, 8 M urea,10 mM reduced glutathione. The solution
was applied to a DEAE cellulose column at room temperature, washed
with 20 mM Tris/HCl (pH 8.0), 10 mM reduced glutathione, 0.25 M
KCl, and eluted with 20 mM Tris/HCl (pH 8.0), 0.5 M KCl, 10 mM
reduced glutathione, 7 M urea. The eluate was dialyzed against stand-
ing tap water (twice the eluate volume) for 24 h, and against slowly
running tap water for 48 h. A water hose with an open side hole was
used to facilitate air oxidation. The folded protein was puriﬁed using
ion exchange chromatography on a DEAE Sephacel column in
20 mM Tris/HCl, pH 7.8, 1 mM CaCl2, and eluted using a linear salt
gradient up to 0.2 M NaCl in the same buﬀer. The purity of the protein
was conﬁrmed by agarose gel electrophoresis, SDS–PAGE, and 1H
NMR spectroscopy.
2.2. HAMLET production
15N-labeled human recombinant a-lactalbumin or human milk a-
lactalbumin, was converted to HAMLET with fully 13C-labeled oleic
acid (Martek Bioscience Corp., Columbia, MD, USA) using the meth-
od described before [1]. The activity of lyophilized HAMLET against
tumor cells was conﬁrmed as described [1].
2.3. NMR samples
Lyophilized HAMLET (5–15 mg) was dissolved in 350–500 ll H2O
containing 5–10% D2O, 0.15 M NaCl, 0.1 mM NaN3, and 1 mM
DSS at pH 7.3–7.5. The samples were transferred into 5 mm Shigemi
tubes and sealed.
2.4. NMR spectroscopy
2D proton and heteronuclear NMR spectra were recorded on a
Varian Unity Inova 500 MHz NMR spectrometer using 5 mm inverse
or triple resonance probes with pulsed ﬁeld gradient capabilities. Theblished by Elsevier B.V. All rights reserved.
Fig. 1. 2D projection from 3D 13C-edited 1H–1H NOESY-HSQC spectra of oleic acid in the HAMLET-bound (b, d) and free (c) states at 37 C.
Resonances are labeled according to the numbering scheme shown in (a). Resonances from residual EDTA (*), and cross-peaks between oleic acid
and protein (**) or water (***) are indicated.
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and the 13C carrier to 45 ppm for methyl and methylene carbons, or
130 ppm for methine carbons. Water presaturation was used. 1H–
15N heteronuclear single quantum correlation (HSQC) spectra were
recorded with spectral widths of 6000 Hz for 1H and 1800 Hz for
15N, using 2048 and 128 complex data points in the acquisition (t2),
and indirect (t1) dimensions, respectively.
1H–13C HSQC spectra were
recorded with spectral widths of 10000 Hz for 1H and 6000 Hz for 13C
using 2048 and 256 complex data points in the t2 and t1 dimension,
respectively. 3D 13C-edited 1H–1H nuclear Overhauser enhancement
spectroscopy (NOESY)-HSQC spectra were recorded for unlabeled
protein and 13C-labeled oleic acid at 20 and 37 C with spectral widths
of 6000 and 5600 Hz in the 1H dimension (t1 and t2) and 10000 Hz in
the 13C dimension (t3) using 4096, 2048 and 512 complex data points,
respectively. The mixing time was 50 ms. 13C-edited COSY and 13C-
edited TOCSY spectra for oleic acid peak assignments were acquired
using spectral widths of 8000 Hz for 1H using 4288 and 300 complex
points, respectively, in the two 1H dimensions. Spectra were processed
using a fourth order polynomial solvent ﬁlter, Lorentzian/Gaussian
and sine-bell window functions in the direct and indirect dimensions,
respectively, and zero ﬁlling to twice the number of collected data
points. NMRPipe, NMRDraw [11] and Sparky (T.D. Goddard &
D.G. Kneller (2003), University of California, San Francisco) were
used for processing and analysis of NMR data.
2.5. Structure calculations of bound and free oleic acid
Distance restraints were derived from the cross-peak volumes in
NOESY spectra (Table 2), as calculated by ﬁtting a Gaussian line-
shape to each cross-peak using the program Sparky. The cross-peak
between C2H and C3H was used for calibration, assuming an average
proton–proton distance of 2.3 A˚. In case of overlap, the volumes weredivided by the product of the numbers of possible contributing protons
in each group, thus, yielding an upper limit on the distance. The Gro-
macs molecular dynamics (MD) software package [12,13] was used to
calculate a model of oleic acid in HAMLET. A topology ﬁle for oleic
acid was constructed on the PRODRG server [14], using the oleic acid
structure in liver fatty acid binding protein (L-FABP, PDB accession
number 1LFO) as a template. The simulations used the Gromacs force
ﬁeld, ﬀgmx2, which is based on the GROMOS-87 force ﬁeld [15], and a
simple point charge (SPC) model for water molecules. One oleate mol-
ecule was put in a cubic box with one sodium counter ion and 284
water molecules. The starting structure was subjected to energy mini-
mization using a steepest descent algorithm, followed by a 5 ns
(2500000 time steps) long MD simulation at 310 K and 1 bar using
Berendsen temperature and pressure coupling [16]. The radius of gyra-
tion was used to monitor when equilibrium was established. Two MD
simulations were performed, one without (‘‘non-restrained’’) and one
with (‘‘restrained’’) NMR-derived distance restraints included with
high standard force constants. An ensemble of 10 MD structures
was collected at 500 ps intervals from 500 to 5000 ps. The structures
were aligned and visualized using the Molmol software [17].3. Results and discussion
3.1. NMR spectra of unbound and bound oleic acid
The 1H and 13C assignments for free and bound oleic acid
were performed using 13C-edited COSY spectra to work out
the scalar couplings along the carbon chain, and are reported
in Table 1 and Fig. 1. Chemical shift diﬀerences are observed
Table 1
1H and 13C chemical shifts (d, ppm) for free and bound oleic acid
Carbon
no.a
d
(1H, free)
d
(1H, bound)
d
(13C, free)
d
(13C, bound)
2 2.29 2.24 38.01 39.72
3 1.64 1.60 28.06 28.84
8/11 2.09 2.02 30.08 29.62
9/10 5.43 5.33 132.38 132.88/131.97
18 0.96 0.90 16.87 16.72
4–7, 12–15 1.39 1.30 32.41 32.40
17 1.44b 1.43 25.89b 23.09
16 1.35 1.29 34.90 34.74
X 1.37 1.32 25.28 25.42
X, not assigned.
aProtons are numbered according to their attached carbon, see Fig. 1(a).
bOverlapped.
Table 2
NOE cross-peak volumes
Cross-peaks NOE volume Scaling factor Distance (A˚)
2 () 3 2.0 · 109 4 2.30b
2 () 8/11 8.0 · 108 8 3.01
2() a 6.4 · 109 – –
2 () 18 2.1 · 109 6 2.44
3 () 8/11 6.7 · 108 8 3.10
3() a 8.7 · 109 – –
3 () 18 1.8 · 109 6 2.50
8/11 () 18 2.7 · 109 12 2.63
8/11 () a 1.2 · 1010 – –
a() 18 6.6 · 109 – 0
9/10 () 8/11 1.9 · 109 – –
9/10 () a 2.5 · 109 – –
9/10 () 18 1.2 · 108 6 3.93
The scaling factor based on the product of the number of protons
potentially contributing to the cross-peaks and the calculated NOE
distances are provided for the constraints used in the restrained MD
simulation.
a4–7, 12–16 Overlapped peaks.
bReference distance.
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changes upon binding to the protein. The 13C-edited 1H–1H
NOESY-HSQC spectra of uniformly 13C-labeled oleic acid in
water contain only a small set of NOE cross-peaks between
protons that are close in sequence (Fig. 1(c)); hence, the fatty
acid is predominantly extended, and/or interconverts between
a large number of energetically equivalent conformations.
The 13C-edited 1H–1H NOESY-HSQC spectra of oleic acid
in HAMLET are similar at 37 C (Fig. 1(b) and (d)) and
20 C (data not shown). These spectra have broader lines
compared to free fatty acid, reﬂecting a slower rotational dif-
fusion of the protein–oleic acid complex. This veriﬁes that
oleic acid is bound with high aﬃnity in the complex. Strong
NOE cross-peaks are observed between the ends of the fatty
acid chain (Fig. 1). This implies that the fatty acid is folded
so that these protons at the two ends are close to one another.
Alternatively, two molecules of oleic acid interacting in an
anti-parallel fashion would also yield cross-peaks between
the two ends. However, stoichiometry studies of the complex
have indicated that one oleic acid is bound per a-lactalbumin
chain [8], making this interpretation less likely. While a 2:2
complex would be consistent with both the NOEs and the
stoichiometry, gel ﬁltration indicates that dimers or higher or-
der oligomers represent a maximum of 2–5% of the sample
(data not shown). Furthermore, magnetic resonance disper-
sion (MRD) measurements [30] show that there is a maximum
of 5% dimers in a 1.3 mM HAMLET sample with no added
calcium or salt (M. Gottschalk, personal communication).
Based on this result, together with the fact that the NOE be-
tween the two ends of oleic acid is of comparable intensity
with those of the NOEs between vicinal protons (Table 2),
we conclude that the end-to-end NOE cannot be dominated
by the small population of dimer, but must be present also
in the monomeric population. The NOEs between each end
and the protons surrounding the double bond suggest a fur-
ther coiling of the fatty acid to yield a signiﬁcantly compacted
structure.
3.2. Fatty acid structure
MD simulations based on the present data were used to pro-
vide a structural view of oleic acid in HAMLET compared to
free oleic acid. The restraints listed in Table 2 include two
unambiguous NOEs, CH2–CH18 and CH3–CH18, in addition
to a strong cross-peaks between CH18 and CH8/11, two med-
ium cross-peaks between CH2 and CH8/11 and between CH3and CH8/11, and a weak cross-peak between CH18 and CH9/
10. These six constraints were used as distance restraints in one
MD simulation. A parallel simulation was performed without
restraints. The radius of gyration reached a stable value after
350 ps in both the restrained and non-restrained simulation.
The 10-membered ensemble from the restrained simulation
has an RMSD of 2.0 A˚. As seen in Fig. 2(a), there are a num-
ber of similar conformations that fulﬁl all the NOE con-
straints, and all of them are signiﬁcantly compacted. The
ensemble hence reveals a compact structure in which the two
ends are close to one another and also close to the cis double
bond. The binding of oleic acid in a preferred conformation
suggests speciﬁcity in its interactions with the protein. A com-
pact oleic acid can be accommodated in a hydrophobic cleft as
suggested [8], while a straight fatty acid would reach through/
across the protein. A number of protein structures with bound
oleic acid have been reported, with both extended and U-
shaped fatty acid (Fig. 2(c)).
Without restraints, the MD simulation yields an extended
oleic acid conformation (Fig. 2(b)) with an RMSD of 2.6 A˚.
The larger RMSD compared to the restrained simulation re-
ﬂects a larger conformational freedom of the free oleic acid.
3.3. Fatty acid–protein contacts
Close proximity between speciﬁc protein moieties and bound
oleic acid gives rise to NOE cross-peaks. Positive NOE cross-
peaks are observed between oleic acid protons resonating at
1.3 ppm (i.e., protons on carbons 4–7 and/or 12–15) and pro-
tein resonances at 4 and 7 ppm (marked ** in Fig. 1(d)) with
temperature-dependent intensities. These cross-peaks are se-
verely broadened due to conformational exchange dynamics,
and could not be assigned to speciﬁc amino acids nor aid in
locating the fatty acid binding site, since statistically, the pro-
tein chemical shifts of the NOESY cross-peaks can occur for
virtually all amino acid types (http://www.bmrb.wisc.edu/).
In addition, negative NOE cross-peaks are observed between
oleic acid and water, which could implicate long-lived water
molecules in the vicinity of the bound oleic acid [18]. Alterna-
tively, these cross-peaks may be mediated by exchange between
water and labile protons in the protein side chains that are
close to the bound oleic acid [19].
Fig. 2. Snap shots from the restrained simulation of oleic acid in
HAMLET (a) and the mean structure from the unrestrained (b)
simulation of oleic acid in water. Examples of oleic acid bound to liver
fatty acid binding protein (1lfo) and human serum albumin (1gni) are
given in (c). The carboxylic oxygens are shown in black, the double
bond carbons in dark grey and the rest of the carbon chain in grey. The
ﬁgure was produced using MolMol software [17].
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Random coil and largely unstructured protein segments
give narrow NMR signals and limited dispersion of proton
resonances, but better dispersion of nitrogen resonances.
Folded proteins yield broader signals, and large chemicalshift dispersion, and this is seen also for native human a-
lactalbumin (C. Redﬁeld, personal communication). Molten
globules and partly folded proteins yield very poor disper-
sion and severe line broadening. 1H–15N HSQC spectra of
HAMLET at 15, 20, 27, and 37 C (Fig. 3) have poor chem-
ical shift dispersion and a limited number of signals. The
spectrum at 37 C has only a small number of resolved
peaks and several broad signals. The NMR spectra for
HAMLET are distinctly diﬀerent from those of native and
apo a-lactalbumin, with fewer resolved peaks, yet contain
a larger number of signals than the pH 2 molten globule
of human or bovine a-lactalbumin that yield only a few
N-terminal peaks [25–28]. Instead, the 1H–15N HSQC spec-
tra of HAMLET are similar to the pH 2 spectrum for gui-
nea pig a-lactalbumin [25] with a somewhat larger number
of resonances. Resonances from side chain amides appear
at 7.5/113 and 6.8/113 ppm, while most other signals from
HAMLET are clustered between 7.5 and 8.7 ppm in the
1H dimension. (The signal that moves from 5.8/109.5 to
5.8/113.5 ppm at 37 C is a folded Arg side chain resonance.)
At 37 C, two peaks are found at 10.4 and 10.2/131 ppm
that are attributed to tryptophan indole N–H. The resolu-
tion is marginally better at lower temperature, but the over-
all features remain the same. Clearly, there are two sets of
signals, one set of relatively narrow lines and one set of se-
verely broadened resonances. The number of narrow signals
increases with decreasing temperature, presumably due to a
decrease of the rate of amide proton exchange with solvent
in the unfolded regions that give rise to these narrow peaks.
The largest changes in the spectra occur between 27 and
37 C, and around 20% of the resonances in the protein
are visible at 15 C. This is the same temperature range
where the largest changes are observed in the near-UV circu-
lar dichroism (CD) spectrum of HAMLET [10]. Together,
these results imply changes in tertiary interactions, corre-
sponding to either a shift in the average coordinate positions
or to a narrowing of the coordinate distributions In con-
trast, the far-UV CD spectrum is largely unaﬀected across
this temperature range, implying that secondary structure
is largely maintained [10]. The NMR spectral characteristics
of HAMLET suggest a partially folded structure in fast to
intermediate exchange. There is no indication of extensive
aggregation under the present conditions (cf. above).
The classical molten-globule like states of a-lactalbumin
are not signiﬁcantly populated under physiological condi-
tions, but are induced by changes in environmental parame-
ters, for example by lowering the pH, raising the
temperature, or adding ethylenediamintetraacetic acid
(EDTA), reducing agent or denaturant [20–23]. In contrast,
the kinetically trapped HAMLET retains its molten glob-
ule-like characteristics at physiological conditions
[1,9,10,24]. This property, as well as the anti-tumor activity
of HAMLET, are strictly dependent on the presence of
bound oleic acid or vaccenic acid [8]. While both straight
and compact conformations of oleic acid are observed in
the structures of other fatty acid binding proteins (with
examples in Fig. 2(c)), a-lactalbumin apparently needs to
bind the fatty acid in a compact conformation in order to
convert into HAMLET, yielding an altered structure with
a new function. In conclusion, HAMLET is both structur-
ally and functionally distinct from other known oleic acid
binding proteins.
Fig. 3. 15N HSQC spectra of HAMLET in 0.15 M NaCl, pH 7.4, at: (a) 15 C; (b) 20 C; (c) 27 C; (d) 37 C. All spectra were plotted using a signal
threshold set just above the noise level in spectrum (d).
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